griswolds. artis duran song of the month. >> don't miss it! my mission is simple, to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now! hey, i'm cramer. welcome to "mad money." welcome to cramerica. friends. i'm just trying to make you some money. my job is not just to entertain you, but to educate and teach you. so call me at 1-800-743-cnbc or tweet me @jimcramer. how do you remove the fed and oil from the story of this market? how do we get the focus back on individual companies, not the overall obsession with what the fed will do on wednesday or what
on a minute to minute basis? both of these factors were in play again today as usual. in a deceptively quiet market with the dow ultimately selling off just four points, s&p closing essentially flat, nasdaq down 0.18%? we know all about the linkage between oil and the averages. but the fed, i've got to tell you, i just hate bringing this to you. i hate bringing it up because everyone else talked about it. sometimes there's no avoiding it. we know t hear. that the fed is now on hold, perhaps until we start to see stronger retail sales manufacturing reports. the decline in so many sectors
but tech was about how the fed might say or do the wrong thing. more say than do. either give us some stern language about the need for another rate hike before the end of the year, or maybe they even do shock us with an outright rate increase, something most people say is highly unlikely, but that's what worries me the most, especially because we saw declines that would seem to indicate otherwise in the last couple weeks. over the course of my career, i've often found that if everyone is worried about a big, bad event, you better be pr to do afterwards. and that usually means knowing what's going to go up once the event is over. what makes stocks go up after a big, bad event like the fed meeting? simple. other than small movements in
out of the market, the buyers are almost totally sidelined. they're paralyzed. they don't know what to do going into the event, while sellers let's talk amazon. i'm going to use that as an analog for how to take the other side of the groom trade that might be busted after the big, bad event. last week we spent days promoting how negative and delivering alpha conference were about the stock market. they were so gloomy that maybe we should rename the conference dangerous alpha. now, the coming apocalypse that many of these money managers predicted might actually come true if central bankers the
betting on. oh, let's be clear. you're kidding yourself if you think those that cry wolf aren't betting against the market at the same time. if the wolf actually shows, they'll be able to make some money. but when i examined my notes from last week, i found an idea that the crowd treated as kind of a throwaway. some minor comment from bill miller, the only panelist i caught up with who was really pound the chest outright bullish on the market, and his idea? buy amazon. i think it's worth going over suggestions because frankly they really make sense to me as a place to go after the fed meeting. miller, a famous stock picker, started by saying he liked facebook, google, and amazon. two reasons. one being that he wanted to make clear his growth bona fides. but, two, he also knew they were all probably reviled by the audience because they're obvious and beloved by retail investors. hence why they're despised by the far more cerebral hedge fund intelligentsia in the room. i'm only being half facetious or sarcastic or sardonic. you take your pick. why does miller like one obvious name, amazon, over the other
going after the same $500 billion advertising market, and even though that's a huge pie they're splitting, he pointed out that amazon has its sights set much higher. the $5 trillion retail market. so, therefore, it's an inherently better story. bigger tam, total addressable market. at one point there was a time when amazon was primarily a book seller. back then, you could sniff at that $5 trillion comment. but is there any doubt now that all retail is vulnerable to amazon? i mean all of it. i mean what is it that they than any of the bricks and mortar places? there's a handful of things, but you know they may not even matter. it's not just the size of the market the company wants to dominate. it's how fast amazon plans on doing it. as miller put it, and i quote, we've never seen a company with $100 billion in revenues growing last quarter at 30% with 40% growth in operating cash flow, end quote. that is stunning. then there's the web services
fulfillment business. 30% margins and they're growing. miller made a comment i should have asked him about, which was his assertion that amazon has a three-year lead. i wish i had asked him over who. i don't see anyone else on the horizon, although last week oracle said it offers a superior cloud product, something reiterated today by co-founder larry ellison. and walmart has acquired online bargain basement jet.com. that deal, i think, closes on wednesday, this week, in an effort to catch up. and i like that deal. i think that nolan has a lot of good things to say. how about amazon's bleeding foray into the rest of the world? right now, bill miller points out that the margins are at zero for its international business. however, he thinks they're headed to 7%. that will be gigantic for amazon. if things don't degrade, if they keep at these levels, miller said the stock could -- i almost hesitated to say it -- double. double in three years. that's right. 775 goes to 1,550. three years.
i bet the majority of people in that room just like so many other big time money managers, who make decisions every day based on the larger issue, the fed, just dismissed this idea as cockamamy. what does amazon have to do with when janet yellen puts that quarter point rate hike through? what does that have to do with wednesday's fed statement? when these managers speak of the equity markets being subject to a central bank crushing, isn't amazon the kind of equity they're talking about? here's the whole point of the exercise i'm bringing to you today. the reason you want to buy amazon is precisely because it has nothing to do with the fed, nothing. amazon is something that many people love, and they can't seem to live without, particularly prime. however, to these fund managers in that big room, all that good work by jeff bezos, the ceo, means nothing because all they can see is a series of rate hikes that will crater anything, everything in its path. so they don't try to distinguish among companies. me, i distinguish. i think bill miller has got it right. amazon's what wins, not loses on
it's not a bond market equivalent. you won't meet a retailer who doesn't stay up at night worrying about amazon regardless of the fed. they just don't talk about it. and that want change after wednesday. i have a whole host of examples of how much money could have been made if you weren't so freaked out about wednesday's meeting. there's tech data, a company we like because it's a supermarket of tech. at a time when components are experiencing an upswing, today tech data spent $2.6 billion in cash and stock to buy avnets worldwide technology solutions. it's business is one whole product line that it has. how did tech data do? it's up 22% on the news. i like that. then there's sarepta therapeutics, a stock that rallied 74% on fda approval of a drug to combat muscular dystrophy, or information technology company infoblox, which rallied 15%. however, these are all relatively unknown or small companies, so i can understand you don't want to mess with those ahead of the fed. but that's not the case with the
is amazon. this is a company with a beloved product. this is as close as you can get to being immune to the fed. the bottom line is you can be paralyzed. you can be sidelined. you can dread the future, or you can find situations right in front of you that can be bought. this can be bought both before or after the fed meeting just in case the fed does absolutely nothing as long as you aren't so scared that you can't think or so frightened that you refuse even to try to make money on what you see, on what you know, and on what you love. darryl in california. darryl. >> caller: hi. i've owned disney stock for a few years and you have said own it, don't trade it. what do you say now? >> i am not deviating from that. i think that one day disney will get out from under this espn conundrum that people are cutting the cord. why? because they have good management and good properties. now, i am saying near term i don't see a catalyst, okay? we've had a lot of catalysts. i'm not being oblivious. longer term, i'm talking about
maybe that's not your time frame. dean in ohio, dean. >> caller: hey, jim. earlier in the summer, you had the ceo of hasbro on your show for an interview. at the time, there was a discussion about what was called good inventory, that the company was holding was the company that holding up pre-holiday season. >> right. >> caller: how do you feel about now investing in hasbro? >> i don't know. 2.5% yield? i thought he was very compelling. i would be a buyer of hasbro for the long term. mattel doesn't have the momentum of hasbro, and mattel keeps going higher. i like hasbro. all right. you want to fret over the fed or every tiny move incrued? this is, by the way, the fed. >> the house of pain. >> be my guest, but that's not my style. i like to find situations that rise above central banks or commodity concerns, and that's
as much as 2% before losing steam today. with so many unknowns about its next move, i'm looking at companies taking action and making profits in the process. you don't want to miss that. then that coach purse may cost a pretty penny, but could an investment in the brand pay you back with interest? with the hand ringing retail impacting the company, i'm eyeing its potential. and shares of seres therapeutics are down over 60% year to date. i'm giving you my take on the speculative biotech stocks. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to firstname.lastname@example.org or give us a call at 1-800-743-cnbc. miss something?
why am i so devastatingly handsome, i'm in a fragrance... ...ad, and my sweethearts gone sayonara. this scarf, all that's left to remember. what! she washed this like a month ago! how's a guy supposed to move on! the long lasting scent of gain flings. "why are you checking your credit score?" "you don't want to live with mom and dad forever, do you?" "i'm making smoothies!" "how do i check my credit score?" "credit karma. don't worry, it's free."
i absolutely love my new york apartment, but the rent is outrageous. good thing geico offers affordable renters insurance. with great coverage it protects my personal belongings should they get damaged, stolen or destroyed. [doorbell] uh, excuse me. delivery. hey. lo mein, szechwan chicken, chopsticks, soy sauce and you got some fortune cookies.
opportunities in the oil stocks as long as you know where to look. three weeks ago i told you how much i like the high quality exploration production companies that keep issuing stock in order to buy lucrative oil and gas assets at terrific prices. these opportunistic oil companies like sm energy, pioneer natural resources, they've all snatched up acreage where they can turn a profit by drilling. strategy. it's certainly been terrific for their stock prices versus the rest of the energy sector. so when anadarko petroleum announced they were acquiring freeport-mcmoran's deep water assets, you better believe that deal caught my attention. i think this is a brilliant move by anadarko that's going to pay off big time. first let me give you a little background on these two moves. freeport used to be a copper and gold miner, but back in -- they
including the debt to buy two oil companies, plains exploration and mcmoran's oil and gas. it turns out the timing of this deal was just terrible. once the price of oil started to collapse in 2014, freeport became a play on three of the weakest commodities around, and the stock got completely obliterated. now fre port is up nearly 50% year-to-date but only because the stock was beaten down to six bucks and change. since oil, copper and gold have rebounded from their lows. still fre port has a ton of debt, $17 billion after the sale of its deep water assets that we're talking about here. if i were them, i'd want out of the oil business as fast as possible now that it's stabilized and they can get a not terrible price for their assets. how about anadarko petroleum, the buyer? this is a well run exploration production company with a stock that's more than doubled from its january lows not long before the bottom in the price of
learned that anadarko was buying freeport's freeport-mcmoran's deep water holding for $2 billion, this is part of what free port got over thee years ago. wow, not bad. what makes this transaction so attractive? it doubles their ownership in the valuable lucius development. anadarko already runs a facility there that's doing quite well with 400 million barrels of oil equivalent. buying these assets from freeport will boost anadarko's production. and more than 87% of it is crude. 80%, that's good because we're not making a lot of money on natural gas these days. this is a super low cost oil that doesn't run out nearly as fast as an onshore prospect. the acquisition development costs for these properties should come in roughly 13.50 per barrel. at 43 bucks that's not bad, right? even if crude goes back to the low 30s, anadarko could still
over the next five years if oil stays where it's currently trading, management believes this acquisition could generate an additional $3 billion in free cash flow for the company. that's huge, especially since anadarko only paid $2 billion to get the assets. as the ceo put it in a conference call, this extremely attractive transaction was accomplished by purchasing assets at a very attractive price from a motivated company, they couldn't really afford to haggle hard on price. anadarko by the way, since it's got adjoining acreage, it was the best deal in the world for them. these deep water assets are such a cash cow, they'll actually allow anadarko to boost its onshore drilling budget. anadarko now says they're going to triple production from these two areas over the next five years, bringing it up to 600,000 barrels of oil equivalent per day.
this was a smart deal for anadarko. how did the company pay for it? you guessed it. they did a secondary offering, selling more than 35 million shares at 54.50 a snap. given that the stock is three bucks higher, anybody that got it on the secondary last week should pat themselves on the back. put it all together and anadarko shelled out $2 billion for a very attractive asset that's going to become a huge cash generator after they spend a little money developing it. we know the company will use that extra cash to build out its incredibly profitable oil feeds in texas. bruce kamich absolutely loves anadarko's chart here. could work its way back to the 70s. bruce is pretty negative. when i looked at this, i was saying, wow, here's a winner. let me give you the bottom line. we've seen a lot of independent oil companies snapping up undervalued assets and then selling their own stock to cover the price tag. but as far as these deals go, anadarko's purchase of freeport-mcmoran assets last week i'm say is one of the i've
the transaction is a huge positive for anadarko which is getting this offshore property at bargain basement prices and frankly i think the stock deserves to go higher short and long term even if oil stalls out at these prices, which to be clear are much higher than anadarko's production costs either offshore or on the ground. much more "mad money" ahead. coach seems to be manning a come back but the stock fizzled out since then. es then did you see sarepta therapeutics soar today? although that's the best case scenario for a speculative biotech, it doesn't always turn out that way. i'm focusing on the other side of the coin to keep your cash vaccinated and warn you about what can go wrong. why don't you stick with cramer?
i want you to stay this bright blue forever... that's why you will stay in this drawer... forever. i can't live without you. and that's why i will never, ever wash you. protect your clothes from the damage of the wash with downy fabric conditioner. it not only softens and freshens... it helps protect clothes... from stretching, fading and fuzz... so your favorite clothes stay your favorite clothes. downy fabric conditioner
back in late january, coach just reported a fantastic quarter, and it seemed like the handbag and accessories retailer was on the road to recovery after spending years lost in the wilderness. for the next five months, coach stock kept climbing higher, all the way up to $43, reflecting what looked like a very real comeback. but two months ago the stock stalled, and since then it's been going steadily downhill, at least until today when coach rallied more than 2.5% up to nearly $36 based on positive reports. what's happening here? has coach's comeback already fizzled out to nothing, or is this a quality stock that was simply dragged down because the entire retail cohort went out of style on -- let's take a closer
we can learn something from it. after putting up mediocre numbers for ages, this market darling delivered a straight-up earnings beat. the beleaguered stock immediately jumped 10% on the news, kicking off an extended rally for a number of reasons. first coach's once ailing north american business posted a same stores decline of just 4%. not a good number in absolute terms but much better than the 9.5% decline in the previous quarter or the 19% decline in the quarter before that, or the 23% decline in the quarter before that one. second, coach finally delivered positive revenue growth up 4.5% after a long period of shrinkage thanks in large part to the brilliant acquisition of stuart weitzman. third, china seemed to be rebounding for coach. that represents the future of coach's growth.
kick-started a turnaround when he took over the reins in january of 2014. before luis took over this company, well, let's just say it was the problem child of the accessories industry. for one thing coach had diluted its brand offering too many products that made their products seem less exclusive for the consumer that had made up their key demo. i'd said they overexpanded and junked up their brand. victor luis came in and hit the ground running with an overhaul of the brand and the business. he closed underperforming stores in smaller metro areas, shifted the company's focus toward major north american markets. he redesigned many of the key products. he overhauled the company's e-commerce business. he also started installing shop managers at coach's shop-within-a-shop department store locations.
stores lately. they look much better than they used to. best of all, he wisely snapped up stuart weitzman for $574 million in cash. it had been part of a private equity firm in january of 2015. that gave him a coveted luxury footwear brand to go with the bags. by the time coach reported at the end of this january, the numbers were beginning to reflect real strength from all of these changes. i was convinced the turnaround was truly to him. so what happened since then? while the stock has gone on a roller coaster ride, falling back to $35 friday before bouncing up to $36 today, the fact is that coach's fundamentals have continued to improve. considering late april, coach reported another clear top and bottom line beat with the flat north american same-store sales. again, while flat numbers, i know they're unimpressive, that marked a major improvement from the kind of gigantic double-digit declines the
then in mid-august, coach delivered another earnings beat. even as the revenues came in a bit light. more important, the company's sales grew by 2% year-over-year positive. that was the first annual growth in ages. meanwhile, the ceo says coach is pulling its products from a number of less ritzy department stores in order to rebuild the brand's exclusivitct he also told us that the retail renovations are still on track. that sounds pretty good, right? these last two quarters made me feel like coach had truly got its act better. but since reporting in august, the stock has now traded down from $40 to $35.94. even though a couple of analysts have upgraded the stock in the interim. i think this is mostly about the macro. we see some weak retail numbers like that august decline and suddenly investors want to sell
every retailer under the sun, including this one. however, there's at least one brokerage firm that doesn't believe in coach's comeback regardless of the mac rowe. last weekend a very damning report. analysts at morgan stanley published a note down grading the stock to underweight. wall street's speak for sell, calling the whole turnaround into question. their logic? morgan stanley believes while coach has been hitting their targets, they've been doing it an unhealthy way. i according to morgan stanley, coach's newfound growth is too driven by promotional activity within their outlet channel, something that has increased steadily over the past four quarters, hence why the company's gross margin in north american business declined by 210 base points during the same period. now, you throw in the fact that coach will soon be coming up much more difficult comparisons, not to mention the soft macro numbers and the slow down in tourist spending and morgan stanley doesn't believe the company can continue to deliver the same stores sell growth it
higher. i felt it was a stinging rebuke of the story. so now i got to ask does morgan stanley's bearish theory have any legs? well, i don't know. in the wake of today's nice bump, i'd say it's the bear's theory is losing its adherence. the detractors seem to be winning. look, i hate promotional activity as much as the next guy. discounting your merchandise is a great way to wreck profits. but remember coach has said they're pulling back from less fancy wholesalers like macy's, which is where the bulk of this promotional activity is happening. they're doing the right thing. my best is they can boost their same-store sales for the same reason. victor luis said, these renovations have been driving significant inflections from previous trends and comps, which exceeds the balance of the fleet in the vast majority of stores.
working and that's a big reason why two different firms, piper jaffray and jefferies came out this very morning on the heels of that morgan stanley sell call to reaffirm their buy recommendations. great minds think alike. we can now focus on that tremendous opportunity in china. coach is paying you to wait. it's got a notoriously b.i.g. dividend yield. i like that. let me give you the bottom line on coach. based on these numbers, we really have to take issue with that extreme morgan stanley sell call. we think the turn around at coach is looking very real. given that the stock has come down a quick $7 over the past couple months, i think it's hard to argue that coach has rallied too far too fast here. the darn thing sells for less than 15 times next year's earnings estimate. worst case scenario, you get a brand that's turning around at a price that represents an even
think coach truly belongs. paul in utah, paul. >> caller: hey, jim, can i get a baba booey? >> baba booey. there you go. what's up? >> caller: i'm looking at l brands. they're working on capturing a market share. goldman sachs has a target price of about 30% above where it is. but i'm wondering if i should continue to hold on. >> look, i thought the goldman call was a very good one. i went over that with a fine toothed comb, remember, pink is doing very well. bath and body works is doing very well. les wexner has put in a whole team there. i think l brands represents a great opportunity at 72. i'm with goldman sachs on that call. john in my home state of new jersey, john. >> caller: cramer, how are you doing?
>> caller: good. i need to know fitbit on this. it took a beating on that one shall and i need to know if it's going to get back. >> here's my problem with fitbit. i liked it higher, so i feel there are some stocks when you're going to call me on this network and you ask me what i think, and i'm going to say, look, i liked it. too high. i don't really know if i'm the call on fitbit. i got fitbit wrong. i believe in the company, but i got it wrong, so some could say, oh, so he likes it now. he liked it much higher. the comeback at coach i think is for real. a reinvigorated management team is making the right moves to reposition. it's a premiere brand. much more "mad money." after sarepta's over 70% move higher today. feel like it's time to go hunting for the next speculative biotech? don't make a move before you hear what i have to say. then did you notice the roller coaster action on the averages today? it all comes back to oil. i'll tell you why crude's in control. and all your calls rapid fire in tonight's edition of the lightning round.
anyoit your numbers go up, despite your best efforts. but what if you could turn things around? what if you could... love your numbers? discover once-daily invokana?. it's the #1 prescribed sglt2 inhibitor that works to lower a1c. a pill taken just once in the morning, invokana? is used along with diet and exercise to significantly lower blood sugar
to be more effective at lowering a1c than januvia. invokana? works around the clock by reducing the amount of sugar allowed back into the body, and sending some sugar out through the process of urination. and while it's not for lowering systolic blood pressure or weight loss, it may help you with both. invokana? can cause important side effects, including dehydration, which may cause you to feel dizzy, faint, lightheaded, or weak, upon standing. kidney problems, genital yeast infections, changes in urination, high potassium, increases in cholesterol, risk of bone fracture, or urinary tract infections, possibly serious. serious side effects may include ketoacidosis, which can be life threatening. stop taking and call your doctor right away if you experience symptoms. or if you experience symptoms of allergic reaction such as rash, swelling, or difficulty breathing or swallowing.
problems or are on dialysis. tell your doctor about any medical conditions and medications you take. using invokana? with a sulfonylurea or insulin may cause low blood sugar. it's time to turn things around. lower your blood sugar with invokana?. imagine loving your numbers. there's only one invokana?.
did you see sarepta therapeutics rocketing higher today? the small cap biotech stock was catapulted into the stratosphere, rallying nearly 74% on news that the fda had approved their treatment for muscular dystrophy, a genetic condition that causes muscular here's the thing about the stock. it was obliterated in january when the fda expressed doubts about the efficacy of the same drug. that news cause the 9 stock to plummet down to $14 in a single session. now it's just under 50 bucks, and after a year where everything biotech got hammered bases on fears that washington might try to regulate drug prices, the bulls finally had
happened to this company today is what i call the best case scenario in you're investing in a speculative biotech stock. finally got fda approval for some wonder drug, which the company will always be able to make a fortune selling it. i heard about people talking about it as a takeover target. but not every developmental stage biotech story plays out this way. in fact, sometimes the data turns out to be disappointing or even extremely disappointing, or the fda blocks a company's key drug and its stock goes into free fall. that's the worst case scenario. that's why these early stage biotechs are inherently speculative. that's why i always warn you about them. so let's consider a case that many of you know. let's consider seres therapeutics. we know it as the micro, mcrb is the letters for the symbol. we had seres on a bunch of times.
i was impressed with their science. now, seres spent the first seven months of 2016 bouncing between the mid-20s and the mid-30s. but then disaster struck. near the end of july, seres reported some disappointing clinical trial data for its key drug and in one day -- one day -- the stock lost nearly 70% of its value. it plunged from $35 down to $10 and change. since then, seres has worked its way back up to $10.55, but the stock is still down huge from ago. so what really went wrong here with this once promising biotech name that i know a lot of you felt were -- well, let's say promising as i did? and is there any way it can get back on track? before we can figure out what to do with thing, you have to understand what the company does. to simplify a complicated subject, it's focused on creating a whole new class of medicines to treat diseases
technical term for when the bacterial ecosystem living in your body somehow becomes imbalanced. you've got trillions of different bacteria living inside you in your digestive packs. you see those flora drugs that make your digestive track right, well, there are billions in there. they're essential to your health that they work well. but when that ecosystem gets out of whack, maybe you've got too many of one kind of bacteria, too few of another, it can make you very sick. combinations of microbes that are supposed to make this internal ecosystem healthy again. the company's lead drug, the one that caused the stock to implode over the summer, is a single-dose pill that prevents recurrent cdi, and that's an inflammation of the large intestine that's the number one cause of hospital acquired infections in the u.s. and this terrible disease kills 29,000 americans a year. now, seres came up with a treatment that was supposed to
doctor gives you antibiotics but the antibiotics also disrupt the healthy bacteria in your gut, making it likely you'll get infected all over again. in other words, the current standard of care can make this disease go away, but it can't make the disease stay away. seres thinks they've come up with a way to prevent cdi from occurring by getting your gut bacteria into healthy equilibrium. this drug is currently in phase two clinical trials and with somere what happened? seres treatment was supposed to reduce the relative risk of czi recurrence, but at eight weeks it had failed to meet its end point. while their drug did do better than the placebo, the difference wasn't statistically significant, and that's what caused the stock to lose nearly 70% of the value in one day. also it really doesn't look good, i know many of you told me on twitter that the ceo and two other executives sold big slugs of stock right before the news broke.
sales were made on what's known as a preprogrammed trading plan, and therefore it's unrelated to the suboptimal findings but i know that doesn't make you feel any less aggrieved. but -- this is a very big but. the ceo repeatedly stressed the trial data is only preliminary. the study remains ongoing. it's supposed to last 24 weeks, which means it's possible the final data could look a lot better, particularly since the results in the previous clinical trial were so strong. sadly, that wasn't enough to prevent the analysts from ganging up on the stock. they think it's less likely the drug will be approved. even if everything does work out, they expect the process to take longer after the set back.
conducting an intensive analysis. i think they're being pretty rigorous about it. at the time seres has other drugs in the pipeline, but they're still in phase one and we know it's going to be years before we see anything. not a reason to own the stock. so where do we go from here? generally speaking, nothing is more binary than an infant biotech stock. either your drug gets approved or it fails. binary. either you're rocketing to the sky like sarepta, or you're plummeting in the abyss like seres. likely get full clinical trial results by the end of the year and at this point it seems like into the stock price which means like if anything goes right here, then seres could have tremendous upside. if the data remains ugly, the stock already has been crushed. seres has a clean balance sheet, no debt, 211 million in cash. that was one of the reasons i
nestle clearly had checked it out. nestle is a big ticketed partner. let me give you the bottom line. i know there's not much to like about seres therapeutic down here. but if you're looking something to speculate on, i think the risk is a lot better than with many other biotechs because this one has already been laid to waste and any good news will send it soaring. this is for speculation only, not an investment, which means you should only put money in seres or similar early-stage biotechs if it's money ye "mad money" is back after the break. the what? tissue test! hold this up to your teeth. ugh yellow. i don't get it. i use whitening toothpaste. what do you use? crest whitestrps. you should try them! whitening toothpaste only works on the surface. but crest whitestrips safely work below the enamel surface to whiten 25x better than the leading whitening toothpaste. you used the whitestrips.
>> it is time! it's time for the lightning round! when you hear this sound -- [ buzzer ] -- then the lightning round is over. are you ready, skee-daddy? it's time for the lightning round on cramer's "mad money." let's start with lee in california. lee. >> caller: booyah. >> booyah. >> caller: buy, sell, or hold color ax? >> i'd like to hold it. clorox is doing down 18 straight points from its high. i don't know, if that stock breaks 120 and gets to be almost a 3% yield, then i say without hesitation right now because that group is really under pressure. alex in florida. alex. >> caller: hey, jim, booyah, how are you? >> all right. how are you? >> caller: hey, i'm good. i got a request on energy nrp. i got this back in may when it hit about 16 and started going back up, dropped off about a month later and then -- >> it's unbelievable.
worth more but that balance sheet is not that good. i don't want to sell it down here, but i got to tell you if it does go back to $16, $17, sell, sell, sell. barry in new york. barry. >> caller: teva, buy, hold or sell. >> they are front and center. front and center in the war. i wouldn't touch that stock until after the election. andy in california. andy. >> caller: hey, jim. a big lasd booyah. how are you doing? >> i don'tw still a believer? >> this thing is unbelievable. they got cut in half even though i know that -- there's a series of price cuts now in steel, but at $4, i am not a seller of ak. new corps did cut its earnings estimates last week and that was very jarring to me. sammy in louisiana, sammy. >> caller: booyah, jim. you're always going to be the
i miss louisiana. i'd love to go back. what's happening? >> caller: come by shreveport one day. that would be cool too. >> i've been there many times. the hospitality is incredible. how can i help? >> caller: what do you think about the stock kellogg's? >> this thing has got three down and five up. that's not that great. this stock acts much better than -- take a look at what happened with campbells. kraft heinz today just got crashed. reward. let's go to hans in florida. >> caller: i bought tractor supply stocks in may. since then, it has dropped 30% to date, and it's basically 20% drop in september. >> i think it's way overdone hans. i really have to tell you i thought that the company -- i know the weather was really bad. this is a well run company.
that, ladies and gentlemen, is the conclusion of the lightning round. >> announcer: the lightning round is sponsored by td ameritrade. really? i'll take it. sir, your credit... -is great right? when was the last time you checked? yeah, i'd better check my credit score. here, try credit karma. it's free. all right. no more surprises. credit karma. give yourself some credit. hi! welcome to the katy kat collection. my new mascara katy kat eye it's the all-day 360 cat eye ten times volume, darkness and no smudging katy kat eye and new katy kat matte lipstick from me and easy, breezy, beautiful
it's so crazy. i almost struggle to believe it. yet it just keeps happening. i'm talking about the incredible endless linkage between the s&p 500 and oil with crude calling the tune every time it rallies or falls off, which literally was the case all day. we started the session strong when oil was roaring but then tapered off when oil surrendered some of its gain. with oil closing near the lows of the day, so did the averages. given the big oil glut, we all know about it, how did crude manage to rally so huge this morning? up almost $1 from the get-go. simple. every time oil goes down to the low 40s, like it did last week after a persistent hammering, we get a rumor from oil producers that a production freeze is imminent. sure enough, this weekend the desperate but very shrewd oil ministers played their parts to
here's how it works in the face of a mountain of oil swirling. first take a look at a reuters story that ran under the headline, venezuela said opec non-opec oil stabilizing deal close. with a date line of margarita island, where there was a summit of the non-aligned movement. the statement couldn't have been more definitive and i quote again. venezuelan president said on sunday that opec and non-opec un and he aimed for a deal this month. that's always part one of the rumor. a statement from the man who needs oil to go higher more than any other leader in the world, the president of venezuela, whose country is falling apart before our very eyes. next we need a call to action from someone else besides the totally lacking credibility venezuelan government. sure enough who weighs in right
in the next paragraph of the story, opec's secretary general, who gets quoted as saying, and i quote, opec members may call an extraordinary meeting to discuss oil prices if they reach consensus at an informal gathering in algiers this month. wait a second. that's not enough. we need one more thing. we need another party that might be able to talk cutback. sure enough, guess who was at the non-aligned movement summit at margarita island, which by this time is turning into margaritaville for the producers, none on that the iranian president,no who desperately needs oil to go higher. rouhani made it clear that tehran supports any move to stabilize the global oil market and lift prices. now, finally we need -- what do we need? we got the guy call, we got a second guy. we got a third. we need a venue. we got that too. with a well-timed quote at the end of the article. opec members will meet on the
energy forum which groups producers and consumers in algeria from september 26th to september 28th. let's see. now we've got venezuela on record wanting something good to happen with oil prices, same with iran. the formula to get oil up needs a big -- sure enough, this story has everything. non-opec producer russia is also attending the forum, end quote. oil heads right back up on the news, ramping 90 crepts, take the dow jones average right up triple digits at the opening. usual algorithms say if you think oil is going higher, buy stocks. maybe the market is getting a little smarter. still we have to ask how come this knee jerk rallying keeps happening? that's simple.
wants to cut back production and risk losing market share to the u.s., which is ready to take advantage of any production freeze that raises price. so they go through the charade. the oil market buys into it and they get the job done. once again, without ever really having to cut production, and everybody swallows it from the journalists to the stock traders to the futures traders in the oil pit. according to my count, this is the sixth time this game has played out already this year. six! it usually works like a charm until we run into an unmovable object like wednesday's actual or, get this, the real opec meeting that comes and goes with no results whatsoever, which always seems to be the case anyway. this kind of rumormongering still does exactly what the world's oil ministers want. it's incredible. it's ridiculous, but it works every time. stick with cramer. olay regenerist renews from within... plumping surface cells for a dramatic transformation -without the need for fillers.
olay regenerist. olay. ageless. and try olay luminous evens tone for radiant, glowing skin. if your sneezes are a force to be reckoned with... you may be muddling through allergies. try zyrtec? for powerful allergy relief. and zyrtec? is different than claritin?. because it starts working faster on the first day you take it.
bull market somewhere. i promise to try and find it just for you right here on "mad money. the suspect put his hand on the side and pulled out a handgun. >> did you know what your son was doing? >> no. >> you had no idea? >> we have directly linked rahami t >> new details surrounding new motives in how the suspect may have been radicalized. >> now, donald trump is calling for racial profiling while hillary clinton has a vastly different reaction. all this as president obama prepares to address the united nations today. >> battles near aleppo rage on. could today's u.s./russia talks change all that. >> outrage in tulsa after police